Optimization of the Generation and Propagation of Gutless Adenoviral Vectors
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Adenoviral vectors devoid of all viral coding regions are referred to by many names, including gutless vectors. Gutless vectors display reduced toxicity and immunogenicity, increased duration of transgene expression, and increased coding capacity compared to early generation vectors, which contain the majority of the viral backbone genes. However, the production of gutless vectors at a scale and purity suitable for clinical use has limited the utility of this technology. In this work we describe the optimization of the production of gutless vectors. We constructed an improved helper virus and generated an alternative gutless vector producer cell line, PERC6-Cre. We demonstrated increased gutless vector yields, minimal helper virus contamination, and no replication-competent adenovirus contamination using the optimized system. Furthermore, the PERC6-Cre cells were adapted to serum-free suspension culture and high-titer gutless vector preparations were produced using bioreactor technology, suggesting the feasibility of gutless vector scale-up for clinical use. Finally, we observed that helper virus lacking a packaging signal could be packaged at a low frequency, revealing an inherent limitation to the differential packaging strategy for gutless vector propagation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parks, R. J., Chen, L., Anton, M., Sankar, U., Rudnicki, M. A., & Graham, F. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13565 · Cited by 725 · cited 1×
“Here, the packaging signal in the helper virus is flanked by loxP sites (floxed), which, in the presence of Cre recombinase, results in its excision (Parks et al ., 1996).”
Gorziglia, M. I., Kadan, M. J., Yei, S., Lim, J., Lee, G. M., Luthra, R., & Trapnell, B. C. (1996) · Journal of Virology · doi:10.1128/jvi.70.6.4173-4178.1996 · Cited by 193
Self-citation
Cited by
Gene Therapy Leaves a Vicious Cycle
Goswami, R., Subramanian, G., Silayeva, L., Newkirk, I., Doctor, D., Chawla, K., Chattopadhyay, S., Chandra, D., Chilukuri, N., & Betapudi, V. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00297 · Cited by 347
Gutless adenovirus: last-generation adenovirus for gene therapy
Alba, R., Bosch, A., & Chillon, M. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302612 · Cited by 303
Gene therapy progress and prospects: adenoviral vectors
St George, J. A. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302071 · Cited by 294
Improved system for helper-dependent adenoviral vector production
Palmer, D., & Ng, P. (2003) · Molecular Therapy · doi:10.1016/j.ymthe.2003.08.014 · Cited by 290
Viral vector‐based gene therapies in the clinic
Zhao, Z., Anselmo, A. C., & Mitragotri, S. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10258 · Cited by 269
Metadata
- Authors
- Sakhuja, K., Reddy, P. S., Ganesh, S., Cantaniag, F., Pattison, S., Limbach, P., Kayda, D. B., Kadan, M. J., Kaleko, M., & Connelly, S.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 2003-02-10
- Volume
- 14
- Issue
- 3
- Pages
- 243-254
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W2003279028
- Cited by
- 75
- References
- 2
- FWCI
- 5.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Optimization of the Generation and Propagation of Gutless Adenoviral Vectors. https://app.cochat.ai/papers/10.1089/10430340360535797
- The paper
- Sakhuja, K., Reddy, P. S., Ganesh, S., Cantaniag, F., Pattison, S., Limbach, P., Kayda, D. B., Kadan, M. J., Kaleko, M., & Connelly, S. (2003). Optimization of the Generation and Propagation of Gutless Adenoviral Vectors. Human Gene Therapy. https://doi.org/10.1089/10430340360535797
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.